Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

272 HORSETAIL
HORSETAIL
Scientific names: Equisetum arvense; Equisetum myriochaetum;
Equisetum ramosissimum; Equisetum telmateia
Family: Equisetaceae
Trade and other common names: Bottle Brush; Cavalinha;
Dutch Rush; Horse Herb; Mepentol; Paddock-Pipes;
Pewterwort; Prele; Scouring Rush; Shave Grass; Toadpipe
Category: Anti-inflammatory; Antioxidant; Diuretic
Purported indications and other uses: Oral: Alopecia,
diabetes, hepatitis, bacterial infections, osteoarthritis, pressure
ulcers, urinary tract infections. Topical: burns
Half-life: N/A
Clinically important, potentially hazardous interactions
with: digoxin, diuretics, nicotine
Reactions
Skin
Rash (sic)
Seborrheic dermatitis
(1985): Sudan BJ, Contact Dermatitis 13(3), 201
Other
Anaphylactoid reactions/Anaphylaxis
(2004): Agustin-Ubide MP+, Allergy 59(7), 786
HUMAN PAPILLOMAVIRUS
VACCINE*
Trade name: Gardasil (Merck)
Indications: For prevention of HPV genital warts, cervical
cancers and vulvar dysplasias
Category: Vaccine
Half-life: N/A
Clinically important, potentially hazardous interactions
with: N/A
Reactions
Other
Fever (10.3%)
Injection-site edema (25.4%)
Injection-site erythema (24.6%)
Injection-site pain (83.9%)
Injection-site pruritus (3.1%)
Injection-site reactions
(2004): Fife KH+, Vaccine 22(21–2), 2943
*Note: Against Types 6, 11, 16 and 18 Human Papillomavirus
HYALURONIC ACID
Synonyms: Hyaluronidase; Hyaluronan; Hyaluran; Hyaluronate
sodium
Trade names: Adant; Aquamid; ARTZ; BioHy; DermaDeep;
DermaLive; Hyalgan; Hylaform; Hylan G-F 20 (Synvisc);
Juvederm; Orthovisc; Perlane (Q-Med AB); Restylane Fine Lines
(Medicis); Supartz
Indications: Oral: joint disorders. Injection: adjunct in eye
surgery, viscosupplementation in orthopedics, cosmetic surgery.
Topical: wounds, burns, skin ulcers, stomatitis
Category: Food supplement; Glycoaminoglycan
Half-life: 2.5–5.5 minutes
Clinically important, potentially hazardous interactions
with: NSAIDs, oral anticoagulants
Reactions
Skin
Acne (0.1–29%)
(2002): Friedman PM+, Dermatol Surg 28(6), 491 (0.15%)
Adverse effects (sic)
(2003): Tomas Gil+, Arthritis Rheum 48(3), 866
(2002): Leopold SS+, J Bone Joint Surg Am 84-A(9), 1619 (2–
21%)
(2001): Evanich JD+, Clin Orthop 390, 173 (15%)
(2000): Allen E+, J Rheumatol 27(6), 1572
(2000): Kroesen S+, Clin Rheumatol 19(2), 147 (2 cases)
(2000): Shafir R+, Plast Reconstr Surg 106(5), 1215
(2000): Wen DY, Am Fam Physician 62(3), 565–70, 572 (rare)
(1997): Kirwan JR+, Baillieres Clin Rheumatol 11(4), 769 (%)
(1997): McEwan LE+, Australas J Dermatol 38(4), 187 (29%)
(with diclofenac)
Allergic granulomatous angiitis (Churg–Strauss syndrome)
(2007): Bardazzi F+, JDermatologTreat18(1), 59
(2006): Ghislanzoni M+, Br J Dermatol 154(4), 755
(2006): Vargas-Machuca I+, Am J Dermatopathol 28(2), 173
(2004): Lombardi T+, JOralPatholMed33(2), 115
(2003): Fernandez-Acenero MJ+, Dermatol Surg 29(12), 1225
(2003): Honig JF+, JCraniofacSurg14(2), 197
(2003): Marino AA+, J Bone Joint Surg Am 85-A(10), 2051
(2003): Rongioletti F+, Arch Dermatol 139(6), 815
(2003): Zardawi IM, J Bone Joint Surg Am 85-A(12), 2484
(2002): Friedman PM+, Dermatol Surg 28(6), 491 (rare)
(2001): Zardawi IM+, Pathology 33(4), 519
(2000): Raulin C+, Contact Dermatitis 43(3), 178
Angioedema
(2005): Leonhardt JM+, Dermatol Surg 31(5), 577
Dermatitis (24%)
(1997): Rivers JK+, Arch Dermatol 133(10), 1239 (24%) (with
diclofenac)
Erythema multiforme
(2007): Calvo M+, J Investig Allergol Clin Immunol 17(2), 127
(2003): Young J, JDermatologTreat14(3), 189
Herpes simplex
Inflammation
(2005): Christensen L+, Aesthetic Plast Surg 29(1), 34
(2005): Soparkar CN+, Ophthal Plast Reconstr Surg 21(2), 151
(2003): Hamburger MI+, Semin Arthritis Rheum 32(5), 296
(2001): Filion MC+, J Pharm Pharmacol 53(4), 555
(2001): Martens PB, Arthritis Rheum 44(4), 978
Irritation
(1999): Peters DC+, Drugs Aging 14(4), 313 (with diclofenac)
Necrosis
(2007): Hirsch RJ+, J Drugs Dermatol 6(3), 325
Sarcoidosis
(2005): Dal Sacco D+, Int J Dermatol 44(5), 411